echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > People's Hospital Li Zhanguo's research results on immunotherapy of rheumatoid arthritis published online

    People's Hospital Li Zhanguo's research results on immunotherapy of rheumatoid arthritis published online

    • Last Update: 2022-04-20
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    In March 2022, the research results of the team of Professor Li Zhanguo from Peking University People's Hospital "Double-blind, randomized, controlled study of the efficacy and safety of low-dose IL-2 combined with methotrexate in the treatment of rheumatoid arthritis" (Efficacy and safety of Ld -IL2 in combination with MTX in patients with active RA: a randomized trial) was published online in the authoritative academic journal Signal Transduction and Targeted Therapy (STTT, IF 18.


    Studies have demonstrated the efficacy and safety of low-dose IL-2 in the treatment of rheumatoid arthritis


    In this study, patients with active RA were included in a double-blind, randomized, placebo-controlled study, treated with low-dose IL-2 for 3 consecutive months, and followed up for 3 months


    Clinical efficacy and evaluation indexes of low-dose IL-2 in the treatment of rheumatoid arthritis

    Further analysis in this study found that the treatment was effective in patients with refractory RA with vasculitis


    Dr.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.